about
Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerBridging cell surface receptor with nuclear receptors in control of bile acid homeostasisBile acid signaling and liver regeneration.GPBAR1/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells.Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15/19 signaling to repress bile acid synthesis.Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis.Suppression of autophagic flux by bile acids in hepatocytes.Are GPCRs still a source of new targets?Characterizing ligands for farnesoid X receptor--available in vitro test systems for farnesoid X receptor modulator development.Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.The Hippo pathway in intestinal regeneration and disease.Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4-/- Mice.Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulationCuAAC click reactions for the design of multifunctional luminescent ruthenium complexes.Circadian misalignment and hepatocellular carcinoma incidence in the United StatesPrevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation
P2860
Q26992106-0464F010-0DBD-4E19-9D88-E07B737D1CE7Q27024221-8556FCF0-1602-45C5-A407-0A552CF2C093Q34580008-232B4BCC-7C35-4E8D-B544-A8CDC911CCF5Q35155033-00C886EE-F92D-4815-83B9-2CAC419F133BQ35195305-3E2E6E0D-56BF-4171-9E4F-82479721BE80Q36638394-22819B7E-82FA-4677-8741-D266A96B914FQ37537472-E6C1458B-0C50-49BE-B1A2-E5EBA49627D2Q38129012-5AC0F273-9236-4981-A454-D5624B9FE49DQ38164798-48E638EA-2403-4EC1-8E78-4DF61152CF59Q38752448-C9B08A68-84A7-4A99-8E72-5264F515DEDFQ38826172-5F3E290B-105E-4D18-82AB-AD64744B6201Q41331841-F3C76570-3F24-4AA4-8019-C3EF1C4F5C4CQ42373337-8AEE50F4-EFC8-47D7-B2D9-A8909A7FA495Q42580571-E4441465-3C38-454F-9BF6-25351C3B232EQ53642308-E7B157E5-0FB6-4DFA-86AA-1FB05CECACE8Q55016397-6111D461-0B63-4EBA-AF81-EB7B29E54E21Q57147768-33BE407A-479D-4325-B77F-814F0D1AB857
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bile Acid Receptors and Liver Cancer.
@ast
Bile Acid Receptors and Liver Cancer.
@en
type
label
Bile Acid Receptors and Liver Cancer.
@ast
Bile Acid Receptors and Liver Cancer.
@en
prefLabel
Bile Acid Receptors and Liver Cancer.
@ast
Bile Acid Receptors and Liver Cancer.
@en
P2093
P2860
P1476
Bile Acid Receptors and Liver Cancer.
@en
P2093
Carl Van Ness
Wendong Huang
Xianghui Fu
Xiaoxiao Ma
Xichun Wang
Zhipeng Meng
P2860
P2888
P356
10.1007/S40139-012-0003-6
P577
2012-12-21T00:00:00Z